Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / OYST - Oyster Point launches TYRVAYA Nasal Spray in the U.S.


OYST - Oyster Point launches TYRVAYA Nasal Spray in the U.S.

Oyster Point Pharma (NASDAQ:OYST) announces that TYRVAYA (varenicline solution) Nasal Spray 0.03 mg is now available at U.S. regional wholesalers for distribution to pharmacies. The U.S. FDA had approved TYRVAYA Nasal Spray for the treatment of the signs and symptoms of dry eye disease in October. Dry eye disease is a chronic condition that impacts an estimated 38 million people in the U.S. and is growing in prevalence. Shares up more than 1% post market.

For further details see:

Oyster Point launches TYRVAYA Nasal Spray in the U.S.
Stock Information

Company Name: Oyster Point Pharma Inc.
Stock Symbol: OYST
Market: NASDAQ
Website: oysterpointrx.com

Menu

OYST OYST Quote OYST Short OYST News OYST Articles OYST Message Board
Get OYST Alerts

News, Short Squeeze, Breakout and More Instantly...